FTA-2062

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFTA-2062
Drug Alias NameEP4 agonist (Taisho)prostaglandin E2 receptor 4 agonist (Taisho)FTA-2062EP4RAG
ClassificationSmall molecules
Mechanisms of ActionProstanoid EP4 receptor agonistsImmunosuppressants
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsRejection of organ transplantationInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaisho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammation

Other Information

ATC CodeN/A
Related LinksN/A